Oncologic efficacy of laparoscopic RPLND in treatment of clinical stage I nonseminomatous germ cell testicular cancer.

@article{Nielsen2007OncologicEO,
  title={Oncologic efficacy of laparoscopic RPLND in treatment of clinical stage I nonseminomatous germ cell testicular cancer.},
  author={Matthew E Nielsen and Guilherme Lima and Edward Schaeffer and James Porter and Jeffrey A. Cadeddu and Ingolf Tuerk and Louis R. Kavoussi},
  journal={Urology},
  year={2007},
  volume={70 6},
  pages={1168-72}
}
OBJECTIVES To assess the oncologic efficacy of laparoscopic retroperitoneal lymph node dissection (LRPLND) for clinical Stage I nonseminomatous germ cell tumors (NSGCTs) in a large multi-institutional series. LRPLND is emerging as a less-invasive alternative in the adjuvant surgical treatment of patients with testicular cancer. METHODS The medical records of 120 patients with clinical Stage I NSGCT who underwent LRPLND at one of four institutions in the United States were retrospectively… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 10 extracted citations

Laparoscopic retroperitoneal lymph node dissection for testicular cancer

International braz j urol : official journal of the Brazilian Society of Urology • 2006

Similar Papers

Loading similar papers…